Deriving Risk-Adapted Screening Initial Age of Colorectal Cancer According to Steatotic Liver Disease Subtypes

Background: Evidence on steatotic liver disease (SLD)-specific colorectal cancer (CRC) risk and implications for screening is limited. We aimed to estimate how many years earlier individuals with SLD, including metabolic dysfunction-associated SLD (MASLD), metabolic and alcohol-related liver disease (MetALD), and alcohol-related liver disease (ALD), reach equivalent CRC risk versus those without. Methods: The primary outcome was incident CRC. We used Cox regression models to estimate adjusted hazard ratios (aHRs), population attributable fractions (PAFs), and risk advancement periods (RAPs). A newly developed framework with age-specific national CRC incidence rates was also applied to estimate risk-adapted CRC screening starting ages in large European countries. Results: 191,837participants were included. Compared with no SLD, aHRs (95% CIs) for CRC were 1.17 (1.05–1.32) for MASLD, 1.41 (1.21–1.63) for MetALD, and 1.58 (1.27–1.95) for ALD; PAFs were 4.2%, 3.3%, and 1.6%, respectively; the PAF for MASLD and MetALD was higher than that of family history of CRC (2.4%). These associations were independent of family history of CRC and cardiometabolic risk factors. Consistent with RAPs, these subtypes reached average-risk CRC incidence 2–6 years earlier than individuals without. Results were similar across countries despite variation in absolute incidence. Conclusions: Individuals with SLD show a graded increase in CRC risk corresponding to 2-6 years earlier risk attainment, supporting their consideration in risk-adapted CRC screening strategies.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11293719/v1
Primary Topic
Colorectal Cancer Screening and Detection
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Deriving Risk-Adapted Screening Initial Age of Colorectal Cancer According to Steatotic Liver Disease Subtypes

H Brenner, Jie Jiang, Hongliang Xue, Hengjing Li et al.
Research Square
Colorectal Cancer Screening and Detection
preprint

Deriving Risk-Adapted Screening Initial Age of Colorectal Cancer According to Steatotic Liver Disease Subtypes

H Brenner, Jie Jiang, Hongliang Xue, Hengjing Li, Ruojin Fu, Teresa Seum, Hetong Zhang, Sha Li, Xuechen Chen, Yishuo Zhai, Tiantian Zhang
preprint en

Abstract

Background: Evidence on steatotic liver disease (SLD)-specific colorectal cancer (CRC) risk and implications for screening is limited. We aimed to estimate how many years earlier individuals with SLD, including metabolic dysfunction-associated SLD (MASLD), metabolic and alcohol-related liver disease (MetALD), and alcohol-related liver disease (ALD), reach equivalent CRC risk versus those without. Methods: The primary outcome was incident CRC. We used Cox regression models to estimate adjusted hazard ratios (aHRs), population attributable fractions (PAFs), and risk advancement periods (RAPs). A newly developed framework with age-specific national CRC incidence rates was also applied to estimate risk-adapted CRC screening starting ages in large European countries. Results: 191,837participants were included. Compared with no SLD, aHRs (95% CIs) for CRC were 1.17 (1.05–1.32) for MASLD, 1.41 (1.21–1.63) for MetALD, and 1.58 (1.27–1.95) for ALD; PAFs were 4.2%, 3.3%, and 1.6%, respectively; the PAF for MASLD and MetALD was higher than that of family history of CRC (2.4%). These associations were independent of family history of CRC and cardiometabolic risk factors. Consistent with RAPs, these subtypes reached average-risk CRC incidence 2–6 years earlier than individuals without. Results were similar across countries despite variation in absolute incidence. Conclusions: Individuals with SLD show a graded increase in CRC risk corresponding to 2-6 years earlier risk attainment, supporting their consideration in risk-adapted CRC screening strategies.

Research Square
Jinan University (CN), German Cancer Research Center (DE), Capital Medical University (CN), Southern Medical University (CN), Guangzhou Medical University (CN)
Colorectal Cancer Screening and Detection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon